GeoVax Labs Inc
GOVX
NASDAQ
Biotechnology
$0.72
USD
0.00 (+0.03%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $5.31M
Volume 196.9K
Revenue
$0
TTM
-100.0%
YoY
Gross Margin
—
TTM
— YoY
Net Income
$-20.43M
TTM
+17.7%
YoY
Operating Cash Flow
$-18.37M
TTM
+32.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | +183.5% | -100.0% | -100.0% | -100.0% | -100.0% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 1.5 | 1.3 | 1.4 | 1.4 | 1.3 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 6.3 | 6.4 | 4.4 | 5.3 | 4.4 |
Operating Income | -5.4 | -6.4 | -4.4 | -5.3 | -4.4 |
EBITDA | -5.4 | -6.4 | -4.4 | -5.3 | -4.4 |
Other Income / Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Other Income / Expense | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
Income Before Income Taxes | -5.4 | -6.3 | -4.4 | -5.3 | -4.4 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -5.4 | -6.3 | -4.4 | -5.3 | -4.4 |
Consolidated Net Income / Loss | -5.4 | -6.3 | -4.4 | -5.3 | -4.4 |
Net Income Attributable to Common Shareholders | -5.4 | -6.3 | -4.4 | -5.3 | -4.4 |
Basic EPS | -$8.74 | -$7.75 | -$2.29 | -$2.62 | -$0.97 |
Diluted EPS | -$8.74 | -$7.75 | -$2.29 | -$2.62 | -$0.97 |
Basic Shares Outstanding | 0.6M | 0.8M | 1.9M | 2.0M | 4.6M |
Diluted Shares Outstanding | 0.6M | 0.8M | 1.9M | 2.0M | 4.6M |